Glucocorticoid receptor expression in breast cancer associates with older patient age

Breast Cancer Research and Treatment

Volumn 116, Issue 3, 2009, Pages 441-447

  Belova, Larissa ^a   Delgado, Bertha ^a   Kocherginsky, Masha ^a   Melhem, Amal ^a   Olopade, Olufunmilayo I ^a   Conzen, Suzanne D ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Chicago ^*

Author keywords

Estrogen receptor; Glucocorticoid receptor; Health disparities; HER2; Progesterone receptor; Triple negative disease

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; PROGESTERONE RECEPTOR; ESTROGEN RECEPTOR ALPHA; HER2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AFRICAN AMERICAN; AGE; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; BREAST TUMOR; CANCER STAGING; ENZYME IMMUNOASSAY; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 70349570432     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0136-9     Document Type: Article

References (29)

1. Lien HC, Lu YS, Cheng AL, Chang WC, Jeng YM, Kuo YH et al (2006) Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms. J Pathol 209(3):317-327. doi:10.1002/path.1982
2. Conde I, Paniagua R, Fraile B, Lucio J, Arenas MI (2008) Glucocorticoid receptor changes its cellular location with breast cancer development. Histol Histopathol 23(1):77-85
3. Amsterdam A, Tajima K, Sasson R (2002) Cell-specific regulation of apoptosis by glucocorticoids: implication to their antiinflammatory action. Biochem Pharmacol 64(5-6):843-850. doi: 10.1016/S0006-2952(02)01147-4
4. Casey TM, Plaut K (2007) The role of glucocorticoids in secretory activation and milk secretion, a historical perspective. J Mammary Gland Biol Neoplasia 12(4):293-304. doi:10.1007/s10911-007-9055-3
5. Pang D, Kocherginsky M, Krausz T, Kim SY, Conzen SD (2006) Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis. Cancer Biol Ther 5(8):933-940
6. Runnebaum IB, Bruning A (2005) Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2. Clin Cancer Res 11(17):6325-6332. doi:10.1158/1078-0432. CCR-05-0182
7. Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD (2004) Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 64(5):1757-1764. doi: 10.1158/0008-5472.CAN-03-2546
8. Bamberger CM, Schulte HM, Chrousos GP (1996) Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 17(3):245-261. doi: 10.1210/er.17.3.245
9. Brewer JA, Vogt SK, Sleckman BP, Swat W, Kanagawa O, Muglia LJ (2002) Knock-ins and conditional knockouts: in vivo analysis of glucocorticoid receptor regulation and function. Endocr Res 28(4):545-550. doi:10.1081/ERC-120016839
10. Lien HC, Lu YS, Shun CT, Yao YT, Chang WC, Cheng AL (2008) Differential expression of glucocorticoid receptor in carcinomas of the human digestive system. Histopathology 52(3):314-324. doi:10.1111/j.1365-2559.2007.02953.x
11. Lu YS, Lien HC, Yeh PY, Kuo SH, Chang WC, Kuo ML et al (2006) Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity. Lung Cancer 53(3):303-310. doi:10.1016/j.lungcan. 2006.05.005
12. Rajatapiti P, Kester MH, de Krijger RR, Rottier R, Visser TJ, Tibboel D (2005) Expression of glucocorticoid, retinoid, and thyroid hormone receptors during human lung development. J Clin Endocrinol Metab 90(7):4309-4314. doi:10.1210/jc. 2005-0556
13. Mikosz CA, Brickley DR, Sharkey MS, Moran TW, Conzen SD (2001) Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1. J Biol Chem 276(20):16649-16654. doi: 10.1074/jbc.M010842200
14. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492-2502. doi:10.1001/jama.295.21.2492
15. Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH et al (2007) Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival. J Surg Res 143(1):109-118. doi:10.1016/j.jss.2007.03.085
16. Pasqualini JR, Cortes-Prieto J, Chetrite G, Talbi M, Ruiz A (1997) Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma. Int J Cancer 70(6):639-643. doi: 10.1002/(SICI)1097-0215(19970317)70:6\639::AID-IJC2\ 3.0.CO;2-W
17. Purmonen S, Manninen T, Pennanen P, Ylikomi T (2008) Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells. Oncol Rep 19(6):1627-1634
18. Lange CA (2008) Challenges to defining a role for progesterone in breast cancer. Steroids 73:914-921. doi:10.1016/j.steroids. 2007.12.023
19. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al (2000) Molecular portraits of human breast tumours. Nature 406(6797):747-752. doi:10.1038/35021093
20. Hall RE, Lee CS, Alexander IE, Shine J, Clarke CL, Sutherland RL (1990) Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels. Int J Cancer 46(6):1081-1087. doi:10.1002/ijc.2910460622
21. Krishnan AV, Swami S, Feldman D (2001) Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol 77(1):29-37. doi:10.1016/S0960-0760 (01)00030-9
22. Kinyamu HK, Archer TK (2003) Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression. Mol Cell Biol 23(16):5867-5881. doi:10.1128/MCB.23.16.5867- 5881.2003
23. Clarke M (2006) Meta-analyses of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview. Ann Oncol 17(Suppl 10):x59-x62. doi:10.1093/annonc/mdl238
24. Anderson WF, Pfeiffer RM, Dores GM, Sherman ME (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 15(10):1899-1905. doi:10.1158/1055-9965. EPI-06-0191
25. Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL (2008) Early onset of breast cancer in a group of British black women. Br J Cancer 98(2):277-281. doi:10.1038/sj.bjc.6604174
26. Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW et al (2008) Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat; Epub ahead of print
27. Newman LA, Martin IK (2007) Disparities in breast cancer. Curr Probl Cancer 31(3):134-156. doi:10.1016/j.currproblcancer. 2007.01.003
28. Anderson WF, Schairer C, Chen BE, Hance KW, Levine PH (2005) Epidemiology of inflammatory breast cancer (IBC). Breast Dis 22:9-23
29. Lowenberg M, Stahn C, Hommes DW, Buttergereit F (2008) Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids 73(9-10):1025-1029. doi:10.1016/j.steroids.2007.12.002